Kuranami, Ai
Maruko, Ruka
Maruko, Ichiro
Hasegawa, Taiji
Iida, Tomohiro
Funding for this research was provided by:
JSPS KAKENHI (JP20K09781)
Article History
Received: 10 December 2022
Accepted: 21 April 2023
First Online: 6 May 2023
Competing interests
: Dr. Kuranami has nothing to disclose. Dr. Maruko (R) has nothing to disclose. Dr. Maruko (I) reported grants from JSPS KAKENHI (Grant Number JP20K09781); personal fees from Alcon, Bayer, Canon, Chugai, Nidek, Nikon, Novartis, Santen, Senju, and Topcon outside the submitted work. Dr. Hasegawa reported personal fees from Bayer, Novartis, Alcon, Santen, Kowa, Senju, R E medical, Nikon, JFC, Otsuka and Boehringer Ingelheim outside the submitted work. Dr. Iida reported consulting fees from Bayer, Novartis, Chugai, and Boehringer Ingelheim; personal fees from AMO, Alcon, Bayer, Canon, HOYA, Nikon, Nidek, Novartis, Otsuka, Pfizer, Santen, Senju, and Topcon outside the submitted work.